Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eduardo Useros Rodríguez

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Archivos Espanoles De Urologia|March 15, 2011
Guide wire knot during double J catheter insertion: case reportEduardo Useros Rodríguez, Ignacio Tomás Castillón Vela, María Eugenia León Rueda, et al.
Archivos Espanoles De Urologia|September 11, 2018
[Prostate carcinosarcoma.]Héctor Garde García, Alberto Hernando Arteche, Eduardo Useros Rodríguez, et al.
Clinical Genitourinary Cancer|December 18, 2021
Impact of New Systemic Therapies in Overall Survival in Non-Metastatic Castration Resistant Prostate Cancer: Systematic Review and Meta-AnalysisAlejo Rodriguez-Vida, Andrés Rodríguez-Alonso, Eduardo Useros-Rodríguez, et al.
BMC Cancer|August 7, 2019
Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer: results from a prospective observational study (CAPRO)Javier Puente, Aranzazu González-Del-Alba, Núria Sala-Gonzalez, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Archivos Espanoles De Urologia|March 15, 2011
Guide wire knot during double J catheter insertion: case reportEduardo Useros Rodríguez, Ignacio Tomás Castillón Vela, María Eugenia León Rueda, et al.
Archivos Espanoles De Urologia|September 11, 2018
[Prostate carcinosarcoma.]Héctor Garde García, Alberto Hernando Arteche, Eduardo Useros Rodríguez, et al.
Clinical Genitourinary Cancer|December 18, 2021
Impact of New Systemic Therapies in Overall Survival in Non-Metastatic Castration Resistant Prostate Cancer: Systematic Review and Meta-AnalysisAlejo Rodriguez-Vida, Andrés Rodríguez-Alonso, Eduardo Useros-Rodríguez, et al.
BMC Cancer|August 7, 2019
Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer: results from a prospective observational study (CAPRO)Javier Puente, Aranzazu González-Del-Alba, Núria Sala-Gonzalez, et al.
Pageof 1